In the latest trading session, 1.73 million Boston Scientific Corporation (NYSE:BSX) shares changed hands as the company’s beta touched 0.78. With the company’s most recent per share price at $52.77 changed hands at -$0.23 or -0.43% at last look, the market valuation stands at $77.30B. BSX’s current price is a discount, trading about -4.21% off its 52-week high of $54.99. The share price had its 52-week low at $37.74, which suggests the last value was 28.48% up since then. When we look at Boston Scientific Corporation’s average trading volume, we note the 10-day average is 7.25 million shares, with the 3-month average coming to 7.11 million.

Analysts gave the Boston Scientific Corporation (BSX) stock a consensus recommendation rating of a Buy, calculated at a mean rating of 1.70. If we narrow down to specifics, the data shows that 0 out of 32 analysts rate the stock as a Sell, with a further 5 assigning it an Overweight rating. Of the remaining, 4 recommended BSX as a Hold, 23 felt it is a Buy and 0 rated the stock as Underweight. Boston Scientific Corporation’s EPS for the current quarter is expected to be $0.48.

Boston Scientific Corporation (NYSE:BSX) trade information

Instantly BSX was in red as seen in intraday trades today. With action -1.22%, the performance over the past five days has been red. The drop to weekly highs of 53.71 on Monday, 09/18/23 subtracted -0.43% to the stock’s daily price. The company’s shares are showing year-to-date upside of 14.05%, with the 5-day performance at -1.22% in the red. However, in the 30-day time frame, Boston Scientific Corporation (NYSE:BSX) is 5.14% up. Looking at the short shares, we see there were 12.22 million shares sold at short interest cover period of 1.6 days.

The consensus price target for the stock as assigned by Wall Street analysts is $60.50, meaning bulls need an upside of 12.78% from its recent market value. According to analyst projections, BSX’s forecast low is $55.00 with $68.00 as the target high. To hit the forecast high, the stock’s price needs a -28.86% plunge from its current level, while the stock would need to soar -4.23% for it to hit the projected low.

Boston Scientific Corporation (BSX) estimates and forecasts

Data shows that the Boston Scientific Corporation share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 8.07% over the past 6 months, a 16.37% in annual growth rate that is considerably lower than the industry average of 17.70%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Boston Scientific Corporation will rise 11.60%, while the growth in revenue is estimated to hit 6.10% for the next quarter. Year-over-year growth is forecast to reach 11.10% up from the last financial year.

Consensus estimates given by 23 financial analysts project the company’s revenue in the current quarter to hit an average of $3.47 billion. 23 analysts are of the opinion that Boston Scientific Corporation’s revenue for the quarter ending Dec 2023 will be $3.63 billion. The company’s revenue for the corresponding quarters a year ago was $3.17 billion and $3.24 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 9.60%. The estimates for the next quarter sales put growth at 11.90%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -8.40%. The 2023 estimates are for Boston Scientific Corporation earnings to decrease by -35.10%, but the outlook for the next 5-year period is at 12.48% per year.

BSX Dividends

Boston Scientific Corporation is expected to release its next quarterly earnings report in October.